Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions

Substance Abuse

Volumn 33, Issue 1, 2012, Pages 9-18

  Friedmann, Peter D ^a,b,c   Hoskinson, Randall ^a,b,c   Gordon, Michael ^d   Schwartz, Robert ^d   Kinlock, Timothy ^d   Knight, Kevin ^e   Flynn, Patrick M ^e   Welsh, Wayne N ^f,g   Stein, Lynda A R ^a,b,c   Sacks, Stanley ^h   Oconnell, Daniel J ⁱ   Knudsen, Hannah K ^j   Shafer, Michael S ^k   Hall, Elizabeth ^l   Frisman, Linda K ^m  

^a RHODE ISLAND HOSPITAL   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d FRIENDS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF DELAWARE   (United States)

^f UNIVERSITY OF CONNECTICUT   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h TEXAS CHRISTIAN UNIVERSITY   (United States)

ⁱ TEMPLE UNIVERSITY   (United States)

^j Department of Corrections ^*  (United States)

^k UNIVERSITY OF KENTUCKY   (United States)

^l ARIZONA STATE UNIVERSITY   (United States)

^m NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

more..

Author keywords

buprenorphine; criminal justice; Medication assisted treatment; methadone; parole and probation; prisoners; substance abuse treatment

Indexed keywords

BUPRENORPHINE; METHADONE; NALTREXONE; NARCOTIC ANTAGONIST;

ADDICTION; ADULT; ARTICLE; CRIME; CRIMINAL LAW; FEMALE; HUMAN; INFORMATION PROCESSING; LEGAL ASPECT; MALE; METHODOLOGY; OPIATE SUBSTITUTION TREATMENT; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREGNANCY COMPLICATION; PRISON; STATISTICS; UTILIZATION REVIEW;

ADULT; BUPRENORPHINE; CRIME; CRIMINAL LAW; DATA COLLECTION; FEMALE; HUMANS; MALE; METHADONE; NALTREXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PRISONS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84856890811     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.611460     Document Type: Review

References (25)

1. Oser C, Knudsen HK, Staton-Tindall M, Taxman F, Leukefeld C. Organizational-level correlates of the provision of detoxification services and medication-based treatments for substance abuse in correctional institutions. Drug Alcohol Depend. 2009;103S:S73-S81.
2. Rich JD, BoutwellAE, Shield DC,Key RG,McKenzie M, Clarke JG, Friedmann PD. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;83:411-419.
3. Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD.Methadone and buprenorphine prescribing and referral practices in US prisons: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83-89.
4. Taxman FS, Cropsey KL, Young DW, Wexler, H. Screening, assessment, and referral practices in correctional settings: a national perspective. Criminal Justice Behav. 2007;34:1216-1234.
5. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
6. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 1992;49:881-887.
7. Kranzler HR, Gage, A. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials. The American Journal on Addictions. 2008;17:70-76.
8. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiatemaintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28:321-329.
9. Johnson BA.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol. 2008;75:34-56.
10. Ball JC, Ross, A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcomes. New York: Springer-Verlag; 1991.
11. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290-1297.
12. Joseph H, Stancliff S, Langrod, J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000;67:347-364.
13. Schwartz RP, Jaffe JH,O'Grady K, Das B, Highfield DA, Wilson ME. Scaling-up interim methadone maintenance: treatment for one thousand heroin addicts. J Subst Abuse Treat. 2009;37:362-367.
14. Centers for Disease Control. Epidemiology of HIV/AIDS-United States, 1981.MMWRMorb Mort Wkly Rep. 2006;55:589-592.
15. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. JAcquir Immune Defic Syndr. 1993;6:1049-1056.
16. Jurgens, R. Is the world finally waking up to HIV/AIDS in prisons? A report from the XV International AIDS Conference. HIV AIDS Policy Law Rev. 2004;9:43-44.
17. McSweeney T, Turnbull PJ, Hough, M. Review of Criminal Justice Interventions for Drug Use in Other Countries. London: Criminal Policy Research Unit; 2002.
18. NIH Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280: 1936-1943.
19. Centers for Disease Control. Substance Abuse Treatment for Injecting Drug Users: A Strategy With Many Benefits. Atlanta, GA: Centers for Disease Control and Prevention.
20. World Health Organization. Interventions to Address HIV in Prison: Drug Dependence Treatment. Geneva: World Health Organization; 2007. Available at: http://www.who.int/hiv/ied/EADrugTreatment.pdf. Accessed February 25, 2010.
21. Couture H, Sabol WJ. Prison Inmates at Midyear 2007. Washington, DC: Bureau of Justice Statistics, US Department of Justice; 2008. NCJ 221944.
22. Greifinger, R. Thirty years since Estelle v. Gamble. In: Greifinger R, ed. Public Health Behind Bars: From Prisons to Communities. New York: Springer; 2007:1-11.
23. McKenzie M, Nunn A, Zaller N, Rich JD. Overcoming obstacles to implementation of methadone for prisoners: implications for policy and practice. J Opioid Manage. 2009;5:189-195.
24. Glaze LE, Bonzcar TP. Probation and Parole in the U.S., 2008. Washington, DC: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2009. NCJ 228230.
25. Polcin DL, Greenfield TK. Factors associated with probation officers' use of criminal justice coercion to mandate alcohol treatment. Am J Drug Alcohol Abuse. 2003;29: 647-670.